Key Points
- Insider purchase: CEO Liam Condon bought 5,226 shares at GBX 1,923 on Feb 23 for £100,495.98, a notable management buy following recent selling pressure.
- Johnson Matthey agreed to sell its Catalyst Technologies unit to Honeywell for ~£1.3bn but accepted a roughly 26% price cut (~£475m)
- Shares trade around GBX 1,959 (52‑week range GBX 1,131–2,434); analysts' consensus is a "Moderate Buy" with a consensus target price of GBX 2,268.
Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon acquired 5,226 shares of Johnson Matthey stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of GBX 1,923 per share, with a total value of £100,495.98.
Liam Condon also recently made the following trade(s):
- On Wednesday, February 11th, Liam Condon acquired 10 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,342 per share, for a total transaction of £234.20.
- On Tuesday, January 13th, Liam Condon acquired 10 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,321 per share, for a total transaction of £232.10.
- On Wednesday, December 10th, Liam Condon bought 14 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,013 per share, with a total value of £281.82.
Johnson Matthey Stock Performance
Shares of JMAT stock opened at GBX 1,959 on Wednesday. Johnson Matthey PLC has a 52 week low of GBX 1,131 and a 52 week high of GBX 2,434. The company has a market capitalization of £3.28 billion, a price-to-earnings ratio of -29.73, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a 50-day simple moving average of GBX 2,271.33 and a 200 day simple moving average of GBX 2,100.04. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their price target on Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the stock a "buy" rating in a report on Wednesday, January 21st. Panmure Gordon reissued a "buy" rating and issued a GBX 2,370 target price on shares of Johnson Matthey in a research report on Monday, November 24th. Finally, Berenberg Bank decreased their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,050 and set a "hold" rating on the stock in a research note on Tuesday, November 25th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of GBX 2,268.
Check Out Our Latest Stock Analysis on Johnson Matthey
Johnson Matthey News Roundup
Here are the key news stories impacting Johnson Matthey this week:
- Positive Sentiment: Company insider Liam Condon bought 5,226 shares at GBX 1,923 (≈£100.5k), signalling management buying after the sell‑off — a modest confidence cue for investors. Insider Purchase
- Neutral Sentiment: Deal confirmed: Johnson Matthey will sell its Catalyst Technologies unit to Honeywell for approximately £1.3bn — the transaction proceeds will reduce group exposure and fund strategy, but the final economics were weakened by the price revision. Deal Announcement
- Negative Sentiment: Johnson Matthey accepted a roughly 26% reduction in the sale price for the Catalyst unit (a ~£475m cut), attributed to the unit underperforming — this directly reduces expected cash proceeds and upside from the disposal. Price Cut Report
- Negative Sentiment: Analyst reaction: J.P. Morgan cut its rating on JMAT to “neutral” following the £475m reduction in the deal price, increasing downside risk from lower cash proceeds and weaker near‑term earnings visibility. Analyst Downgrade
- Negative Sentiment: Market impact: Shares plunged roughly 15% as investors priced in the lower sale proceeds and greater execution risk for the Catalyst unit; volatility and lower liquidity can persist while the consequences for group cash and margin are re‑assessed. Share Price Reaction
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
